refimprove|date=September 2014
Drugbox
| verifiedrevid = 447548741

<!--Combo data-->
| type = combo
| component1 = Benzoyl peroxide
| component2 = Clindamycin phosphate
| class1 = Antiseptic
| class2 = Antibiotic

<!--Clinical data-->
| tradename =  
| MedlinePlus = a603021
| licence_EU =  
| licence_US = Duac
| pregnancy_category =  C
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US =  
| legal_status = Rx
| dependency_liability =  
| routes_of_administration = Topical

<!--Identifiers-->
| CAS_number_Ref = cascite|correct|??
| CAS_number =  
| ATC_prefix = D10
| ATC_suffix = AE51
| ATC_supplemental =  
| DrugBank_Ref = drugbankcite|correct|drugbank
| DrugBank =  
| ChemSpiderID_Ref = chemspidercite|correct|chemspider

<!--Chemical data-->

The pharmaceutical drug|drug combination benzoyl peroxide/clindamycin is a topical gel used for the treatment of Acne vulgaris|acne. It is sold under the trade names Duac (by Stiefel Labs) and BenzaClin (by Sanofi Aventis). Both contain 1% clindamycin phosphate and 5% benzoyl peroxide and are prescription drugs.

